Marissa McPhillips met Michelle, in her capacity as CEO of Alltrna, for a constructive conversation around the critical role industry plays in developing innovative treatments for rare disease. We heard how it takes an environment that supports innovation, with incentives, novel clinical trial designs, and other enabling regulations – with Michelle urging the rare disease community to continue to push for these things.

For more information about Alltrna and how they are scaling rare disease drug development by pioneering tRNA medicines to treat Stop Codon Disease, check out their LinkedIn page, YouTube channel, and X account (formerly Twitter).